135 related articles for article (PubMed ID: 31184505)
1. A novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder.
Adams HR; Defendorf S; Vierhile A; Mink JW; Marshall FJ; Augustine EF
Clin Trials; 2019 Oct; 16(5):555-560. PubMed ID: 31184505
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials in rare disease: challenges and opportunities.
Augustine EF; Adams HR; Mink JW
J Child Neurol; 2013 Sep; 28(9):1142-50. PubMed ID: 24014509
[TBL] [Abstract][Full Text] [Related]
3. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
[TBL] [Abstract][Full Text] [Related]
4. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis).
Augustine EF; Beck CA; Adams HR; Defendorf S; Vierhile A; Timm D; Weimer JM; Mink JW; Marshall FJ
JIMD Rep; 2019; 43():117-124. PubMed ID: 29923092
[TBL] [Abstract][Full Text] [Related]
7. Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).
Ouseph MM; Kleinman ME; Wang QJ
Ann N Y Acad Sci; 2016 May; 1371(1):55-67. PubMed ID: 26748992
[TBL] [Abstract][Full Text] [Related]
8. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
[TBL] [Abstract][Full Text] [Related]
9. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
Drack AV; Miller JN; Pearce DA
J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
[TBL] [Abstract][Full Text] [Related]
10. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
[TBL] [Abstract][Full Text] [Related]
11. A novel in-frame mutation in
Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
[No Abstract] [Full Text] [Related]
12. Communicating with participants during the conduct of multi-center clinical trials.
Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
[TBL] [Abstract][Full Text] [Related]
13. Funding resources for rare disease research.
Stehr F; Forkel M
Biochim Biophys Acta; 2013 Nov; 1832(11):1910-2. PubMed ID: 23608548
[TBL] [Abstract][Full Text] [Related]
14. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
[TBL] [Abstract][Full Text] [Related]
15. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
Trials; 2018 May; 19(1):291. PubMed ID: 29793540
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
Tokola AM; Salli EK; Åberg LE; Autti TH
Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
[TBL] [Abstract][Full Text] [Related]
17. Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies.
Augustine EF; Mink JW
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():655-62. PubMed ID: 27491213
[TBL] [Abstract][Full Text] [Related]
18. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
Cudkowicz M; Chase MK; Coffey CS; Ecklund DJ; Thornell BJ; Lungu C; Mahoney K; Gutmann L; Shefner JM; Staley KJ; Bosch M; Foster E; Long JD; Bayman EO; Torner J; Yankey J; Peters R; Huff T; Conwit RA; ; Shinnar S; Patch D; Darras BT; Ellis A; Packer RJ; Marder KS; Chiriboga CA; Henchcliffe C; Moran JA; Nikolov B; Factor SA; Seeley C; Greenberg SM; Amato AA; DeGregorio S; Simuni T; Ward T; Kissel JT; Kolb SJ; Bartlett A; Quinn JF; Keith K; Levine SR; Gilles N; Coyle PK; Lamb J; Wolfe GI; Crumlish A; Mejico L; Iqbal MM; Bowen JD; Tongco C; Nabors LB; Bashir K; Benge M; McDonald CM; Henricson EK; Oskarsson B; Dobkin BH; Canamar C; Glauser TA; Woo D; Molloy A; Clark P; Vollmer TL; Stein AJ; Barohn RJ; Dimachkie MM; Le Pichon JB; Benatar MG; Steele J; Wechsler L; Clemens PR; Amity C; Holloway RG; Annis C; Goldberg MP; Andersen M; Iannaccone ST; Smith AG; Singleton JR; Doudova M; Haley EC; Quigg MS; Lowenhaupt S; Malow BA; Adkins K; Clifford DB; Teshome MA; Connolly N
JAMA Neurol; 2020 Jun; 77(6):755-763. PubMed ID: 32202612
[TBL] [Abstract][Full Text] [Related]
19. The neuronal ceroid-lipofuscinoses.
Goebel HH
J Child Neurol; 1995 Nov; 10(6):424-37. PubMed ID: 8576551
[TBL] [Abstract][Full Text] [Related]
20. Toward protecting the safety of participants in clinical trials.
Califf RM; Morse MA; Wittes J; Goodman SN; Nelson DK; DeMets DL; Iafrate RP; Sugarman J
Control Clin Trials; 2003 Jun; 24(3):256-71. PubMed ID: 12757992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
